Qube Research & Technologies (QRT)
CELG

Qube Research & Technologies (QRT)’s Celgene Corp CELG Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-12,914
Closed -$1.19M – 503
2019
Q2 		$1.19M Buy
12,914
+3,922
+44% +$372K 0.28% 91
2019
Q1 		$848K Buy
+8,992
New +$786K 0.11% 244
2018
Q4 		– Sell
-19,857
Closed -$1.78M – 1069
2018
Q3 		$1.78M Buy
19,857
+19,082
+2,462% +$1.69M 0.24% 75
2018
Q2 		$62K Sell
775
-8,043
-91% -$668K 0.04% 443
2018
Q1 		$786K Buy
+8,818
New +$847K 0.3% 48

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CELG Position: Q3 2019 in Review

Qube Research & Technologies (QRT) sold out of Celgene Corp (CELG) in Q3 2019, closing a stake of 12,914 shares — an estimated $1.19M sold.

Qube Research & Technologies (QRT) first reported a position in CELG in Q1 2018 and held it in 5 quarters. The position peaked at $1.78M in Q3 2018. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

  • Qube Research & Technologies (QRT) reported no remaining Celgene Corp position as of Q3 2019 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 12,914 Celgene Corp shares in Q3 2019, an estimated $1.19M.
  • Qube Research & Technologies (QRT) first reported a position in Celgene Corp in Q1 2018 and held it in 5 quarters.
  • Qube Research & Technologies (QRT)'s Celgene Corp position peaked at $1.78M in Q3 2018.
  • 1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2019, filed 13 Nov 2019.